Health-related non-profit research funding

If you plan to apply for funds...

Please let the indicated Office of Research contact know of your plans to apply as soon as possible. If application review is desired and/or institutional sign-off is required, please provide an electronic copy of your application two weeks prior to the submission deadline.

Note that the Office of Research can assist applicants seeking partnerships (e.g. for applications that require matching funds).

Funding opportunities

Canadian institutions are eligible to apply for all opportunities listed below. The quick list of new opportunities hyperlinks to details. Previously announced and ongoing opportunities follow the detailed list. All details were accurate at time of posting but are susceptible to changes by the sponsor. Always check the sponsor's website for current deadline date. NEW – we now have a separate listing for NIH opportunities following the ongoing opportunities.


New Opportunities (as of 23 September 2020)

Sponsor Quick List

CAAIF/Stallergenes Early Investigator Award in Allergy and Clinical Immunology
Aldrighetti Research Award for Young Investigators
CPFF Research Grants
American Epilepsy Society Seed Grant Program
Michael J. Fox Foundation – Parkinson’s research grants
Ataxia Canada - Research Grants
J Edouard Samson Award for Outstanding Orthopaedic Researcher
2021 ASRP Research Competition
Alzheimer Society of Canada
Canadian Hemophilia Society (CHS)

Details

CAAIF/Stallergenes Early Investigator Award in Allergy and Clinical Immunology:
Contact Lisa Sergovich
The objective of the CAAIF/Stallergenes Greer Early Career Investigator Award in Allergy and Clinical Immunology is to support early career investigators doing research relevant to Allergy and Clinical Immunology. The maximum value of the award is $10,000. Deadline October 1, 2020.

Aldrighetti Research Award for Young Investigators
Contact Lisa Sergovich
The Pulmonary Hypertension Association (PHA) has committed about $8 million to support cutting-edge research on pulmonary hypertension. PHA has supported more than 75 researchers since the association formed 29 years ago. PHA grants support promising PH scientists and clinicians who study new methods for early detection, new treatments to prevent the onset of PH, and ultimately a cure. Deadline October 1, 2020.

CPFF Research Grants:
Contact Lisa Sergovich
In keeping with CPFF’s mission to raise funds to finance research to better understand, develop treatments and find a cure for pulmonary fibrosis, the Foundation offers two, $20,000 research grants each year to fund clinical research relevant to patient care and/or translational research. The research must be done in Canada and be relevant to Canadians and Canadian patients. Deadline October 9, 2020.

American Epilepsy Society Seed Grant Program:
Contact Lisa Sergovich
Seed grants provide up to $20,000 for one year, to be used to cover direct costs to fund preliminary investigation that will help researchers compete for larger grants that cover the full cost of research. They may not be renewed. Deadline October 19, 2020.

Michael J. Fox Foundation – Parkinson’s research grants:
Contact Lisa Sergovich
The Michael J. Fox Foundation supports research projects through six Requests for Applications (RFAs) that span our strategy to define, measure and treat Parkinson’s. Deadline for pre-proposals is October 22, 2020.

Open RFAs  

Ataxia Canada - Research Grants:
Contact Lisa Sergovich
Ataxia Canada funds relevant research where ataxia is the primary symptom and is genetic (recessive, dominant) and progressive in nature. This includes conditions such as Friedreich ‘s ataxia (FA) , Beauce’s ataxia (SCAR8, ARCA1) , spinocerebellar ataxias (SCA), ataxias with oculomotor apraxia (AOA1-4) , episodic ataxias and other cerebellar ataxias.
The candidates are encouraged to seek co-funding from other organizations. We also encourage pan-Canadian collaborative research. Deadline October 30, 2020.

J Edouard Samson Award for Outstanding Orthopaedic Researcher:
Contact Lisa Sergovich
The premier award for orthopaedic research in Canada, the J. Édouard Samson Award, recognizes the best career orthopaedic research over a period of five (5) years or more at a Canadian centre. This $30,000 award is intended to promote further research by the recipient. The recipient will present his/her research at the Annual General Meeting of the Canadian Orthopaedic Association (presentation opportunity to be determined). The award consists of an educational grant and a personal research grant to be used by the recipient at the Canadian institution where he/she currently resides. Deadline October 31, 2020.

2021 ASRP Research Competition
Contact Lisa Sergovich
The Alzheimer Society Research Program (ASRP) is a successful collaborative initiative of our Federation, within which all the provincial Alzheimer Societies, the Alzheimer Society of Canada (ASC), partners and donors pull together to support research directed at both eradicating dementia and ameliorating the lives of those affected by it. The ASRP provides grants and awards to support Canadian studies that promise new insights into causes, prevention, diagnosis, treatment and management of Alzheimer’s disease and other dementias. 6 November 2020.

    • Doctoral Awards provide an opportunity for promising individuals, pursuing a PhD, or combined master’s degrees and PhD, to begin the process of becoming future independent investigators in the field of Alzheimer's disease and other dementias.
    • Postdoctoral Awards are for graduates with a PhD or MD who wish to gain additional research experience within an established research environment.
    • New Investigator Operating Grants are designed to help launch the careers of outstanding researchers who are within the first 4 years of their initial academic appointment.
    • Proof of Concept Grants are designed to fund innovative, potentially high-risk and high-reward research that push beyond the boundaries of our existing understanding of dementia.

Alzheimer Society of Canada:
Contact Lisa Sergovich
Doctoral Awards provide an opportunity for promising individuals, pursuing a PhD, to begin the process of becoming future independent investigators in the field of Alzheimer's disease and other dementias. Deadline: 6 November 2020

  • Amount: $66,000
  • Duration: 3 years
  • Eligibility: Within 18 months of starting PhD program

Postdoctoral Awards are for graduates with a PhD or MD who wish to gain additional research experience within an established research environment.

  • Amount: $100,000
  • Duration: 2 years
  • Eligibility: Within 18 months of obtaining their PhD degree (extension may be given to MDs)

New Investigator Operating Grants are designed to help launch the careers of outstanding researchers who are within the first 4 years of their initial academic appointment

  • Amount: $200,000
  • Duration: Up to 4 years
  • Eligibility: Within the first 2 years of initial faculty position

Proof of Concept Grants are designed to fund established researchers in conducting innovative, high-risk and high-reward approaches to dementia research. Please do not submit existing hypotheses.

  • Amount: $100,000
  • Duration: Up to 5 years
  • Eligibility: Principal investigators must hold a faculty position at a Canadian university or affiliated institution

Canadian Hemophilia Society (CHS)
Contact Lisa Sergovich
First call for applications. Deadline: 16 November 2020

  • Dream of a Cure: the program is no longer limited to hemophilia A & B-related projects so that projects focusing on von Willebrand disease, rare factor deficiencies, platelet function disorders (and platelet pathophysiology) and other congenital and acquired bleeding disorders can be supported;
  • CHS/Pfizer Care Until Cure Research Program: the areas of interest to which investigators are encouraged to submit proposals has been expanded to include mild hemophilia A and B and Factor Utilization & Cost-effectiveness; all projects included but not limited to the list will be considered;
  • CHS/Novo Nordisk Psychosocial Research Programme: applications from Social Workers, Nurses, or Physiotherapists with professional experience in a hemophilia treatment centre (or other comparable settings in which care has been provided to people with hemophilia and other inherited bleeding disorders) or persons interested in the field of inherited bleeding disorders will be considered. Students in a PhD program in one of the allied health disciplines may also apply. Professionals who have appointments in universities and who can dedicate time to research are encouraged to apply. Professional experience in a hemophilia treatment centre is desirable but not required.
  • CHS/Bayer ADVANCE Canada Research Program:  applicant must be a physician or Ph.D. with professional experience in a hemophilia treatment centre (HTC) or other comparable settings in which care has been provided to people with hemophilia and other inherited bleeding disorders. Professionals who have appointments in universities and who can dedicate time to research are encouraged to apply. The proposed research must have relevance to current practice in bleeding disorders care and may incorporate a broad spectrum of quantitative and qualitative research methods addressing professional practice with individuals, families, groups and communities, organizational issues, public health, and education.The research studies should aim to provide better data and tools to help the treaters assist patients in successful ageing.

Previously Announced

Sponsor Quick List

CAAIF/Aralez Pharmaceuticals Canada Inc. Research Grant in Allergic Rhinitis
ALS Canada & Brain Canada 2020 Discover Grants Program
W. Garfield Weston Foundation Brain Health: Lifestyle Approaches and Microbiome Contributions
Alex’s Lemonade Stand – Foundation for Childhood Cancer
Canadian Cancer Society

Details

CAAIF/Aralez Pharmaceuticals Canada Inc. Research Grant in Allergic Rhinitis - deadline extended
Contact Lisa Sergovich
The Canadian Asthma, Allergy and Immunology Foundation (CAAIF) is a charitable foundation whose mission is to invest in research leading to new and better treatments that improve the lives of Canadians living with allergy, asthma and immunologic diseases. Aralez Pharmaceuticals Canada Inc. is a leading Canadian specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products primarily in allergy, dermatology and other specialty areas. The objective of the CAAIF/Aralez Pharmaceuticals Canada Inc. Research Grant in Allergic Rhinitis is to fund a research grant focused on the area of allergic rhinitis. The maximum value of the award is $25,000. Letter of intent deadline 24 September 2020, full application by invite.

ALS Canada & Brain Canada 2020 Discover Grants Program
Contact Lisa Sergovich
Since 2014, ALS Canada’s partnership with Brain Canada has resulted in nearly $20 million being invested in leading-edge ALS research that has helped further the study of the disease. The Discovery Grants Program is designed to fuel the innovation that will accelerate our understanding of ALS, identify pathways for future therapies and optimize care to improve the quality of life for people and families affected by this devastating disease. Deadline 25 September 2020

W. Garfield Weston Foundation Brain Health: Lifestyle Approaches and Microbiome Contributions
Contact Lisa Sergovich
As details emerge of the neurological effects of COVID-19, preventing and maintaining brain health becomes even more critical for the long-term well-being of Canadians. This $7M pilot initiative is designed to support research examining the impact of lifestyle and the microbiome on the maintenance of optimal brain health and, in particular, the prevention or delay of neurodegenerative diseases of aging. Letter of intent deadline 25 November 2020, Proposal deadline 15 April 2020.

Alex’s Lemonade Stand – Foundation for Childhood Cancer
Contact Lisa Sergovich
Alex’s Lemonade Stand Foundation (ALSF) and the RUNX1 Research Program (RRP) are pleased to announce we are now accepting applications for the 2021 RUNX1 Early Career Investigator Grants. These grants promote the establishment of a new generation of translational and clinical researchers interested in tackling inherited hematologic malignancy predisposition disorders that focus on RUNX1-familial platelet disorder. The New RUNX1 Early Career Investigator grant provides $180,000 over three years. It’s designed to fund research leading to the development of therapies to prevent the transition from pre-leukemia to leukemia for patients with RUNX1-FPD. Application deadline 16 December 2020

Canadian Cancer Society:
Contact Lisa Sergovich
Impact Grant
. The Impact Grant program supports significant progression in cancer research programs that are anywhere in the continuum from basic, high impact discovery to translational work of direct relevance to the clinic, to applied research. Impact Grants aim to accelerate and focus the knowledge gained from scientific findings, in the short- to medium-term, into outcomes that will significantly improve scientific knowledge relevant to cancer, result in improved cancer treatment, result in optimized care of people living with and beyond cancer, and result in reduced cancer burden. Budgets awarded will not exceed $300,000 per year, to a maximum of $1,500,000 per grant. The grant term is up to 5 years. Grants will be renewable at the end of their term.  Letter of Intent deadline 29 Apr 2020  Postponed – deadline TBA